Midgard Science

Fermion

Espoo, Finlandfermion.fiFrom their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Fermion develops, manufactures, and markets active pharmaceutical ingredients and offers contract development and manufacturing services for drug substances and drug products. It serves companies in the global generic market and companies focused on new chemical entities, with sites and R&D facilities in Finland.

Services

  • Generic API development, manufacturing and marketing

    Develops, manufactures, and markets active pharmaceutical ingredients for the generic market and under exclusive contracts.

  • CDMO API development services

    Supports drug development at all stages, including route selection, process optimization, scale-up, technology transfer, and regulatory support.

  • CDMO API commercial manufacturing

    Provides commercial manufacturing of active pharmaceutical ingredients, including transfer of validated processes to Fermion sites.

  • Drug product contract manufacturing

    Offers contract manufacturing services for drug products including semi-solids, liquids, oral solids, packaging, and technology transfer.

  • Technology transfer services

    Supports transfer from another manufacturing site or transition from development to commercial manufacturing.

  • Regulatory support

    Provides regulatory support for filings and market authorization preparation, including DMF-related support for CDMO customers.

Capabilities

Assays and studies
  • Analytical development
  • QC testing
  • Impurity profile analysis
  • Process safety testing
  • Reaction calorimetry
  • DSC
  • Method validation
  • Process validation
Scale and capacity
  • Kilo scale unit in Espoo
  • Pilot scale unit in Oulu
  • Three manufacturing sites for drug products
  • One packaging center for drug products
  • Glass-lined reactors up to 6.3 m³

Instruments and platforms

  • DSC
  • Reaction calorimetry

Modalities and species

Modalities
Small molecule

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: sites in Finland

Details

Type
CRDMO
Size
11-50 employees
Based in
Espoo, Finland
Sites
Hanko, Finland · Oulu, Finland · Turku, Finland · Salo, Finland
Serves
Global generic market, USA, China, Japan, Europe, Australia, Taiwan, Brazil, South-Korea, Mexico

Public records

FDA drug establishment registration
3002807817 · ANALYSIS; API MANUFACTURE; LABEL source

Similar labs